Publication:
Effectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22

Simple item page
dc.contributor.authorMartínez-Baz, Iván
dc.contributor.authorCasado, Itziar
dc.contributor.authorMiqueleiz, Ana
dc.contributor.authorNavascués, Ana
dc.contributor.authorPozo Sanchez, Francisco
dc.contributor.authorTrobajo-Sanmartín, Camino
dc.contributor.authorAlbéniz, Esther
dc.contributor.authorElía, Fernando
dc.contributor.authorBurgui, Cristina
dc.contributor.authorFernández-Huerta, Miguel
dc.contributor.authorEzpeleta, Carmen
dc.contributor.authorCastilla Catalán, Jesús
dc.contributor.funderUnión Europea. European Centre for Disease Prevention and Control (ECDC)
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.date.accessioned2023-05-05T07:53:03Z
dc.date.available2023-05-05T07:53:03Z
dc.date.issued2022-06
dc.description.abstractCompared with individuals unvaccinated in the current and three previous influenza seasons, in 2021/22, influenza vaccine effectiveness at primary care level was 37% (95% CI: 16 to 52) for current season vaccination, regardless of previous doses, and 35% (95% CI: -3 to 45) for only previous seasons vaccination. Against influenza A(H3N2), estimates were 39% (95% CI: 16 to 55) and 24% (95% CI: -8 to 47) suggesting moderate effectiveness of current season vaccination and possible remaining effect of prior vaccinations.es_ES
dc.description.peerreviewedSíes_ES
dc.description.sponsorshipThis study was supported by the Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Network funded by the European Centre for Disease Prevention and Control (RS/2021/DRP/12984) and by the Instituto de Salud Carlos III with the European Regional Development Fund (PI20/01323, CM19/00154, and INT21/00100).es_ES
dc.format.number26es_ES
dc.format.page2200488es_ES
dc.format.volume27es_ES
dc.identifier.citationEuro Surveill. 2022 Jun;27(26):2200488.es_ES
dc.identifier.doi10.2807/1560-7917.ES.2022.27.26.2200488es_ES
dc.identifier.e-issn1560-7917es_ES
dc.identifier.journalEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletines_ES
dc.identifier.pubmedID35775428es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15978
dc.language.isoenges_ES
dc.publisherEuropean Centre for Disease Prevention and Control (ECDC)
dc.relation.projectFISinfo:fis/Instituto de Salud Carlos III/Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I/Subprograma Estatal de Generación de Conocimiento/PI20 - Proyectos de investigacion en salud (AES 2020). Modalidad proyectos de investigación en salud. (2020)/PI20/01323es_ES
dc.relation.projectFISinfo:fis/Instituto de Salud Carlos III/Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I/null/Contratos Río Hortega (2019)/CM19/00154es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/INT21/00100es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/RS/2021/DRP/12984es_ES
dc.relation.publisherversionhttps://doi.org/10.2807/1560-7917.ES.2022.27.26.2200488es_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectAcute respiratory infectiones_ES
dc.subjectCase-control studyes_ES
dc.subjectInfluenzaes_ES
dc.subjectInfluenza vaccinees_ES
dc.subjectRepeated vaccinationes_ES
dc.subjectVaccine effectivenesses_ES
dc.subject.meshInfluenza Vaccineses_ES
dc.subject.meshInfluenza, Humanes_ES
dc.subject.meshCase-Control Studieses_ES
dc.subject.meshHumanses_ES
dc.subject.meshInfluenza A Virus, H3N2 Subtypees_ES
dc.subject.meshPrimary Health Carees_ES
dc.subject.meshSeasonses_ES
dc.subject.meshSpaines_ES
dc.subject.meshVaccinationes_ES
dc.titleEffectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication5611ffc3-de88-4908-b20a-9a15a58c060a
relation.isAuthorOfPublication.latestForDiscovery5611ffc3-de88-4908-b20a-9a15a58c060a
relation.isFunderOfPublication78e868cc-0192-448d-bcb1-98d618a7cee4
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublicationefa64f05-b985-4984-8f1e-5fc4ef21f502
relation.isFunderOfPublication.latestForDiscovery78e868cc-0192-448d-bcb1-98d618a7cee4
relation.isPublisherOfPublication844b1441-479c-4219-87e5-efc493160a02
relation.isPublisherOfPublication.latestForDiscovery844b1441-479c-4219-87e5-efc493160a02

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
EffectivenessInfluenzaVaccinationPreventing_2022.pdf
Size:
122.25 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Centro Nacional de Microbiología (CNM)
IdiSNA - Instituto de Investigación Sanitaria de Navarra (Navarra)